K Aigner

679 total citations
23 papers, 537 citations indexed

About

K Aigner is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, K Aigner has authored 23 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Physiology. Recurrent topics in K Aigner's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Obstructive Sleep Apnea Research (3 papers). K Aigner is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Obstructive Sleep Apnea Research (3 papers). K Aigner collaborates with scholars based in Austria, Switzerland and Germany. K Aigner's co-authors include Peter Ettmayer, Walter Lengauer, David Rafaja, Susanne Binder, J. Debuigne, G. Groboth, A. Guillou, J Bolitschek, A Schmeiser-Rieder and Michael Kunze and has published in prestigious journals such as Journal of Clinical Oncology, European Respiratory Journal and Journal of Alloys and Compounds.

In The Last Decade

K Aigner

23 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Aigner Austria	9	279	219	195	131	56	23	537
Ping Ren China	19	547 2.0×	570 2.6×	647 3.3×	90 0.7×	6 0.1×	88	1.2k
Arash Yazdani Iran	13	94 0.3×	152 0.7×	128 0.7×	24 0.2×	35 0.6×	28	400
Sungjun Han South Korea	8	252 0.9×	158 0.7×	46 0.2×	94 0.7×	23 0.4×	21	397
Teng Fei Zhang China	18	190 0.7×	464 2.1×	444 2.3×	48 0.4×	52 0.9×	29	675
M. Talvitie Finland	12	459 1.6×	213 1.0×	65 0.3×	145 1.1×	13 0.2×	14	562
Jenifer Barrirero Germany	14	435 1.6×	407 1.9×	202 1.0×	51 0.4×	10 0.2×	28	642
Ingo Wirth Germany	13	218 0.8×	234 1.1×	205 1.1×	16 0.1×	5 0.1×	70	631
Parimal J. Patel United States	10	81 0.3×	122 0.6×	95 0.5×	124 0.9×	118 2.1×	20	406
L Durand France	21	837 3.0×	366 1.7×	92 0.5×	599 4.6×	5 0.1×	78	1.2k
M. Yoshida Japan	22	601 2.2×	357 1.6×	107 0.5×	38 0.3×	18 0.3×	47	1.2k

Countries citing papers authored by K Aigner

Since Specialization

Citations

This map shows the geographic impact of K Aigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Aigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Aigner more than expected).

Fields of papers citing papers by K Aigner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Aigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Aigner. The network helps show where K Aigner may publish in the future.

Co-authorship network of co-authors of K Aigner

This figure shows the co-authorship network connecting the top 25 collaborators of K Aigner. A scholar is included among the top collaborators of K Aigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Aigner. K Aigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schlick, W, Wolfgang Pohl, Karl Pfeiffer, et al.. (2010). Evaluation of 3–5 months’ add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study. Current Medical Research and Opinion. 26(3). 561–570. 7 indexed citations

Hilbe, Wolfgang, K Aigner, Christian Dittrich, et al.. (2007). Expertenempfehlung 2006 zur rationalen Zweitlinien-Therapie beim nicht-kleinzelligen Bronchuskarzinom. Wiener klinische Wochenschrift. 119(7-8). 259–266. 9 indexed citations

Pirker, Robert, et al.. (2006). Achieving Full-Dose, On-Schedule Administration of ACE Chemotherapy Every 14 Days for the Treatment of Patients with Extensive Small-Cell Lung Cancer. Lung. 184(5). 279–285. 11 indexed citations

Aigner, K, et al.. (2006). Richtlinien für die Pneumologische Rehabilitation (Stand 5.12.2005). Wiener klinische Wochenschrift. 118(15-16). 496–503. 2 indexed citations

Aigner, K, et al.. (2004). Österreichische Gesellschaft für Lungenerkrankungen und Tuberkulose: Konsensus zur Diagnostik und Therapie von Asthma bronchiale bei Erwachsenen. Wiener klinische Wochenschrift. 116(9-10). 339–345. 2 indexed citations

Aigner, K, et al.. (2004). A phase II study of pegfilgrastim to support ACE 14 chemotherapy for the treatment of subjects with small cell lung cancer (SCLC; extensive disease). Journal of Clinical Oncology. 22(14_suppl). 7216–7216. 1 indexed citations

Pirker, Robert, et al.. (2004). A phase II study of pegfilgrastim to support ACE 14 chemotherapy for the treatment of subjects with small cell lung cancer (SCLC; extensive disease). Journal of Clinical Oncology. 22(14_suppl). 7216–7216. 3 indexed citations

Manegold, C., R. Gervais, K Aigner, et al.. (2003). 57 Pemetrexed vs docetaxel: a phase III study in patients with advanced non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy. European Journal of Cancer Supplements. 1(5). S22–S22. 3 indexed citations

Weißenbacher, Ronald, Roland Haubner, K Aigner, & B. Lux. (2002). Interactions of Ta-filaments during hot-filament CVD of BCN-layers. Diamond and Related Materials. 11(2). 191–197. 8 indexed citations

10.

Hainz, Ursula, K Aigner, Peter Berger, et al.. (2002). [Vaccine protection in the elderly: are Austrian seniors adequately protected by vaccinations?].. PubMed. 114(5-6). 187–93. 20 indexed citations

11.

Aigner, K, et al.. (1999). [Austrian Society for Lung Diseases and Tuberculosis: Consensus on diagnosis and therapy of bronchial asthma in adults. Revised draft 1999].. PubMed. 111(24). 1044–7. 2 indexed citations

12.

Bolitschek, J, et al.. (1998). Impact of nasal continuous positive airway pressure treatment on quality of life in patients with obstructive sleep apnoea. European Respiratory Journal. 11(4). 890–894. 43 indexed citations

13.

Prior, C., W. Oberaigner, Erin L. Schenk, et al.. (1997). Adjunctive interferon-alpha-2c in stage IIIB/IV small-cell lung cancer: a phase III trial. European Respiratory Journal. 10(2). 392–396. 18 indexed citations

14.

Aigner, K, Walter Lengauer, & Peter Ettmayer. (1997). Interactions in iron-based cermet systems. Journal of Alloys and Compounds. 262-263. 486–491. 40 indexed citations

15.

Lengauer, Walter, Susanne Binder, K Aigner, et al.. (1995). Solid state properties of group IVb carbonitrides. Journal of Alloys and Compounds. 217(1). 137–147. 181 indexed citations

16.

Lengauer, Walter, Susanne Binder, K Aigner, et al.. (1995). ChemInform Abstract: Solid State Properties of Group IVb Carbonitrides.. ChemInform. 26(22). 1 indexed citations

17.

Aigner, K, et al.. (1994). [Diagnostic process of alveolitis--state of the art].. PubMed. 21(4). 95–9. 2 indexed citations

18.

Aigner, K, Walter Lengauer, David Rafaja, & Peter Ettmayer. (1994). Lattice parameters and thermal expansion of Ti(CxN1−x), Zr(CxN1−x), Hf(CxN1−x) and TiN1−x from 298 to 1473 K as investigated by high-temperature X-ray diffraction. Journal of Alloys and Compounds. 215(1-2). 121–126. 170 indexed citations

19.

Bolitschek, J, et al.. (1990). A screening method for sleep-apnoea detection.. PubMed. 11. 532s–533s. 1 indexed citations

20.

Bolitschek, J, et al.. (1990). [Sleep apnea and the work site].. PubMed. 44(7). 892–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact